Minolira is owned by Epi Hlth.
Minolira contains Minocycline Hydrochloride.
Minolira has a total of 1 drug patent out of which 0 drug patents have expired.
Minolira was authorised for market use on 08 May, 2017.
Minolira is available in tablet, extended release;oral dosage forms.
The generics of Minolira are possible to be released after 07 April, 2036.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US11103517||EPI HLTH||Pharmaceutical compositions for minocycline|| |
(13 years from now)
Market Authorisation Date: 08 May, 2017
Dosage: TABLET, EXTENDED RELEASE;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic